Found 7 resultsAuthor [ Title] Type Year
Filters: Author is Wald, Anna [Clear All Filters]
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.. Vaccine, 33(39), 5225-34. presented at the 2015 Sep 22. doi:10.1016/j.vaccine.2015.06.075. (2015).
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med, 366(1), 34-43. presented at the 2012 Jan 05. doi:10.1056/NEJMoa1103151. (2012).
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis, 56(3), 344-51. presented at the 2013 Feb. doi:10.1093/cid/cis891. (2013).
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. J Infect Dis, 205(5), 703-12. presented at the 2012 Mar 01. doi:10.1093/infdis/jir837. (2012).
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis, 206(6), 811-20. presented at the 2012 Sep 15. doi:10.1093/infdis/jis427. (2012).
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Vaccine, 30(28), 4240-8. presented at the 2012 Jun 13. doi:10.1016/j.vaccine.2012.04.044. (2012).
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis, 203(5), 666-73. presented at the 2011 Mar 01. doi:10.1093/infdis/jiq093. (2011).